BLAIR WILLIAM & CO/IL - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$8,626,672
-1.7%
84,691
-2.6%
0.03%
+3.1%
Q2 2023$8,777,458
+7.5%
86,983
-2.0%
0.03%
-3.0%
Q1 2023$8,166,256
-0.8%
88,764
-2.2%
0.03%
-8.3%
Q4 2022$8,230,139
+9.5%
90,720
-8.2%
0.04%
+2.9%
Q3 2022$7,514,000
-10.2%
98,850
-0.1%
0.04%
-5.4%
Q2 2022$8,364,000
-4.8%
98,950
-1.2%
0.04%
+19.4%
Q1 2022$8,789,000
-0.6%
100,165
-0.9%
0.03%
+10.7%
Q4 2021$8,839,000
+19.1%
101,049
+11.4%
0.03%
+12.0%
Q3 2021$7,421,000
-14.8%
90,745
-5.0%
0.02%
-16.7%
Q2 2021$8,714,000
-21.6%
95,501
-26.5%
0.03%
-28.6%
Q1 2021$11,110,000
-23.3%
129,969
-15.3%
0.04%
-20.8%
Q4 2020$14,487,000
-20.5%
153,413
-26.8%
0.05%
-31.2%
Q3 2020$18,228,000
+6.2%
209,617
+6.6%
0.08%
-6.1%
Q2 2020$17,167,000
-0.6%
196,552
-6.2%
0.08%
-24.1%
Q1 2020$17,269,000
-16.2%
209,445
-3.8%
0.11%
+1.9%
Q4 2019$20,612,000
+35.6%
217,679
+24.5%
0.11%
+20.5%
Q3 2019$15,198,000
-10.3%
174,894
-5.7%
0.09%
-9.3%
Q2 2019$16,937,000
-2.1%
185,489
+3.1%
0.10%
-7.6%
Q1 2019$17,299,000
+13.3%
179,941
+1.1%
0.10%
-5.4%
Q4 2018$15,272,000
+1.4%
177,975
+1.8%
0.11%
+20.7%
Q3 2018$15,059,000
+15.0%
174,778
+0.8%
0.09%
+3.4%
Q2 2018$13,092,000
-10.1%
173,315
-3.7%
0.09%
-13.6%
Q1 2018$14,558,000
-40.2%
180,060
-37.9%
0.10%
-37.6%
Q4 2017$24,331,000
+55.3%
289,788
+58.8%
0.16%
+39.8%
Q3 2017$15,669,000
+5.8%
182,521
+2.9%
0.12%
+6.3%
Q2 2017$14,807,000
+31.7%
177,392
+18.5%
0.11%
+22.0%
Q1 2017$11,240,000
+2.4%
149,649
-0.7%
0.09%
-7.1%
Q4 2016$10,975,000
-4.8%
150,667
+3.2%
0.10%
-3.9%
Q3 2016$11,524,000
-10.7%
145,941
-6.7%
0.10%
-15.0%
Q2 2016$12,906,000
+4.5%
156,416
-8.3%
0.12%
+3.4%
Q1 2016$12,350,000
-17.8%
170,487
-2.4%
0.12%
-17.7%
Q4 2015$15,031,000
-23.6%
174,698
-18.3%
0.14%
-17.1%
Q3 2015$19,666,000
-2.6%
213,956
+4.3%
0.17%
+466.7%
Q2 2015$20,181,000
+5.9%
205,221
+6.2%
0.03%
+3.4%
Q1 2015$19,058,000
-5.4%
193,267
-11.1%
0.03%
-12.1%
Q4 2014$20,150,000
+4.3%
217,466
+5.9%
0.03%0.0%
Q3 2014$19,325,000
+14.9%
205,303
+10.5%
0.03%
+22.2%
Q2 2014$16,813,000
+32.5%
185,722
+24.4%
0.03%
+28.6%
Q1 2014$12,691,000
+8.8%
149,284
+2.9%
0.02%
+10.5%
Q4 2013$11,660,000
-9.2%
145,065
-13.4%
0.02%
-17.4%
Q3 2013$12,846,000
-18.1%
167,472
-24.5%
0.02%
-25.8%
Q2 2013$15,692,000221,9210.03%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders